Showing results (1131-1140 of 2,915) with videos related to
Sort By:
Pageof 292
Cancer Gene Therapy|September 11, 2004
Cancer-specific activation of the survivin promoter and its potential use in gene therapyJin-Shing Chen, Jaw-Ching Liu, Lei Shen, et al.Cancer Gene Therapy|September 11, 2004
Experimental infections of humans with wild-type adenoviruses and with replication-competent adenovirus vectors: replication, safety, and transmissionDrew L Lichtenstein, William S M WoldCancer Gene Therapy|September 18, 2004
Silencing of hdm2 oncogene by siRNA inhibits p53-dependent human breast cancerTie-gang Liu, James Q Yin, Bo-yang Shang, et al.Cancer Gene Therapy|September 18, 2004
Employment of microarray analysis to characterize biologic differences associated with tropism-modified adenoviral vectors: utilization of non-native cellular entry pathwaysAndrea L Volk, Angel A Rivera, Grier P Page, et al.Cancer Gene Therapy|May 1, 2004
Inhibition of B16BL6 tumor progression by coadministration of recombinant angiostatin K1-3 and endostatin genes with cationic liposomesKeun Sik Kim, Hong Sung Kim, Jin Seu Park, et al.Cancer Gene Therapy|July 10, 2004
Use of the EGP-2/Ep-CAM promoter for targeted expression of heterologous genes in carcinoma derived cell linesPamela M J McLaughlin, Monika Trzpis, Bart-Jan Kroesen, et al.Cancer Gene Therapy|December 14, 2004
Anti-tumor effect of hematopoietic cells carrying the gene of ribonuclease inhibitorPanfeng Fu, Junxia Chen, Yuxiang Tian, et al.Cancer Gene Therapy|December 4, 2004
Vascular administration of adenoviral vector soaked in absorbable gelatin sponge particles (GSP) prolongs the transgene expression in hepatocytesByeong-Ho Park, Jin-Hwa Lee, Jin-Sook Jeong, et al.Cancer Gene Therapy|April 9, 2005
Gene therapy vectors containing CArG elements from the Egr1 gene are activated by neutron irradiation, cisplatin and doxorubicinOlga Greco, Tanya M Powell, Brian Marples, et al.Pageof 292